Abstract:Background Pregnancy leads to physiological changes within the cardiovascular system such as increased plasma volume and cardiac output or hypercoagulability. These changes can be challenging for women with pre-existing cardiovascular disease with higher risks of complications. The guidelines of the European Society of Cardiology recommend treating high-risk patients in specialized centres by an interdisciplinary pregnancy heart team. In a team-based approach, the Pregnancy Heart Team was founded at our university hospital, in order to establish specific structures of communication and responsibility. Methods A prospective registry of all patients treated by the Pregnancy Heart Team between November 2022 and March 2024 was established. Patients consisted of women with pre-existing cardiovascular disease undergoing pregnancy as well as women who developed pregnancy-associated cardiovascular disease. Patients were evaluated throughout pregnancy by lab work and echocardiography during each trimester as well as in the postpartum period. Results In total 39 women (mean age 34±5 years) were prospectively included in the registry. 17 patients (43.5%) were classified as mWHO ≥ III. 17 patients (43.5 %) with pre-existing (pregnancy-associated) cardiovascular disease were managed throughout pregnancy and delivery. 9 patients (18.4 %) developed pregnancy-associated cardiovascular diseases such as peripartum cardiomyopathy or spontaneous coronary artery dissection. Preliminary data shows that mean left-ventricular ejection fraction remained stable during pregnancy with a non-significant trend towards lower values postpartum. Cardiac biomarkers such as high-sensitivity troponin T and NT-pro-BNP showed a non-significant trend towards increased values in the third trimester and postpartum. Adverse maternal outcomes occurred in 14 patients (35.9 %), including preterm premature rupture of membranes (12.2%), gestational hypertension (7.6%), gestational diabetes (5.1%), preeclampsia/eclampsia (7.6%) and delivery-associated complications (10.2%). Fetal complications included macrosomia (10.2%) or intrauterine growth retardation (5.1%). Discussion These preliminary data of a real-world patient collectivedemonstrate that a significant number of patients experienced adverse pregnancy outcomes which was associated with a trend towards increased cardiac biomarkers throughout pregnancy and postpartum. As recent studies have shown, interpretation of standard parameters such as cardiac biomarkers is not fully understood during pregnancy, especially in women with pre-existing cardiovascular disease. Our data may aid to understand prognostic implications of cardiac biomarkers during pregnancy.

Fetal Epicardial Fat Thickness in Obese Pregnant Women: Its Effect on Fetal Cardiac Function and Neonatal Outcomes

OP21.06: Tricuspid Annular Plane Systolic Excursion in Evaluation of Right Heart Systolic Function of Fetuses in Second and Late Trimester with Conventional M‐mode and Free Angle M‐mode Echocardiography

Fetal epicardial fat thickness and modified myocardial performance index in late‐onset fetal growth restriction

Obesity in pregnancy is a predictor of persistent subclinical myocardial dysfunction over postpartum period

Impact of maternal diabetes and obesity on fetal cardiac functions

Effect of abnormal placentation on fetal heart function and neonatal outcomes

Influence of Supervised Maternal Aerobic Exercise During Pregnancy on 1-Month-old Neonatal Cardiac Function and Outflow: A Pilot Study

EP15.02: Fetal cardiac function and Doppler studies in obese pregnant women in comparison with non‐obese women

Do Maternal Heart Diseases Affect Fetal Cardiac Functions?

Maternal cardiovascular adaptation to pregnancy in obese pregnant women

Evaluating Maternal Risk Factors Impacting Fetal Intima–Media Thickness of the Abdominal Aorta Measured at 28 Weeks of Gestation

Fetal Growth Ultrasound in Obese Patients for the Detection of Growth Abnormalities

Is It Diabetes or Just Macrosomia? Fetal Myocardial Performance Index in Large-for-Gestational Age Fetuses

The relationship between maternal body composition in early pregnancy and foetal mid-thigh soft-tissue thickness in the third trimester in a high-risk obstetric population

Maternal Overweight Downregulates MME (Neprilysin) in Feto-Placental Endothelial Cells and in Cord Blood

Characterization of fetal cardiac structure and function detected by echocardiography in women with normal pregnancy and gestational diabetes mellitus

Preliminary data on short-term outcomes within the cardio-obstetrics registry

Maternal Cardiac Disease and Perinatal Outcomes in a Single Tertiary Care Center

A new Doppler index, cerebro‐placental‐uterine ratio, and fetal cardiac parameters in early onset preeclampsia

First Trimester Evaluation of Maternal Visceral Fat and Its Relationship with Adverse Pregnancy Outcomes

Fetal cardiac Doppler changes in gestational diabetic pregnancies and its relationship with perinatal outcomes